Throat News and Research

RSS

Patients with Barrett's esophagus benefit from endoscope-based therapies

According to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania, patients with Barrett's esophagus and early or pre-cancerous cells have been shown to significantly benefit from minimally invasive therapy delivered through an endoscope - a medical instrument used to look inside an organ or cavity in the body.

21 Feb 2013

Researchers uncover neurological basis of speech motor control

A team of researchers at UC San Francisco has uncovered the neurological basis of speech motor control, the complex coordinated activity of tiny brain regions that controls our lips, jaw, tongue and larynx as we speak.

21 Feb 2013

SPI Pharma launches Actimask Ibuprofen 92S

SPI Pharma, Inc., a global leader in providing pharmaceutical ingredients and technologies for patient-friendly dosage forms, announces the launch of Actimask Ibuprofen 92S, a taste-masked Ibuprofen.

15 Feb 2013

State roundup: Calif. doc supply strains under health law

The compelling facts and figures he provided the Senate Finance Committee gave feuding Democrats and Republicans the confidence to unite behind an expedited but cautious roadmap toward a federally prescribed expansion of Medicaid in Virginia.

12 Feb 2013

LASAG trial for severe influenza initiated

...

12 Feb 2013

Wichita State associate professor writes two books about flu

The flu: It's a popular topic of conversation lately, as most people probably know someone who has gotten sick this winter. But for Wichita State associate professor George Dehner, the flu is a year-round focus. Dehner, who teaches world and environmental history, recently wrote two books about the flu.

11 Feb 2013

NSU-COM to hold grand opening for America's first Institute for Neuro Immune Medicine

Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) will hold a grand opening for America's first Institute for Neuro Immune Medicine on Feb. 12.

5 Feb 2013

Ten common notions concerning colds and flu

The cold and flu season has hit early and hard this year. As the number of people infected continues to increase, so does the number of internet searches for ways to prevent or limit the duration of viral illnesses. But, what is fact and what is fiction?

1 Feb 2013

Red coloration might represent some physiological benefit: Research

Red coloration-historically seen as costly in vertebrates-might represent some physiological benefit after all, according to research published in the journal Physiological and Biochemical Zoology.

29 Jan 2013

Takeda receives FDA approval for Nesina, Kazano and Oseni to treat type 2 diabetes

The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.

28 Jan 2013

Snoring may indicate future health risks

Here's a wake-up call for snorers: Snoring may put you at a greater risk than those who are overweight, smoke or have high cholesterol to have thickening or abnormalities in the carotid artery, according to researchers at Henry Ford Hospital in Detroit.

25 Jan 2013

Scientists figure out how to dodge HPV-triggered cancers by vaccination

In 2009, more than 30,000 people in the U.S. learned they had cancer linked to the human papillomavirus, or HPV. This virus is best known for causing cervical cancer, but it's also the culprit behind many cancers of the mouth, throat, anus, and genitals. Unlike many forms of cancer, for which we lack the knowledge and tools to prevent, scientists have figured out how to dodge HPV-triggered cancers — by HPV vaccination.

19 Jan 2013

Primary-care clinic treatment improves patient follow up

Treating low-acuity emergency-department patients in a primary-care clinic results in better future primary care follow up, research shows.

14 Jan 2013

Placing peanut protein under a patient's tongue helps dampen allergic reactions

Of all foods, peanuts are the most frequent cause of life-threatening and fatal allergic reactions. New research at National Jewish Health provides additional support for a strategy to reduce the severity of reactions to peanut- repeatedly consuming small amounts of the very food that causes those reactions in the first place, a practice called immunotherapy.

11 Jan 2013

Overall cancer death rates continue to decline in the U.S.: Report

The Annual Report to the Nation on the Status of Cancer, 1975-2009, shows that overall cancer death rates continued to decline in the United States among both men and women, among all major racial and ethnic groups, and for all of the most common cancer sites, including lung, colon and rectum, female breast, and prostate.

9 Jan 2013

Immune response more complicated than thought

Researchers have found that the orientation and concentration of antibodies could determine the control of bacterial infection.

28 Dec 2012

Genetic innovations for pneumonia diagnosis in children

Polymerase chain reaction could help diagnose Mycoplasmia pneumonia infection in children, researchers say.

24 Dec 2012

Pergamum’s DPK-060 Phase II trial on acute external otitis meets primary end-point

Pergamum AB announced today that the primary end-point was met in the randomized Phase II trial of DPK-060 for treatment of acute external otitis.

21 Dec 2012

Tips to prevent food allergies during Christmas

Chestnuts roasting on an open fire, candles filling the air with the smell of cinnamon and beloved decorations making their yearly appearance really do help make the season bright. But for kids with allergies these holiday delights can make the atmosphere miserable and even deadly.

19 Dec 2012

Tacrolimus plus sirolimus not better than standard regimen in preventing GVHD

An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of Hematology annual meeting.

11 Dec 2012